47—lorenzo frontiers paper

Michele Mutti and Lorenzo Corsini of the phage biotech company PhagoMed have published a review on GMP production of phages for therapy. They review the literature covering technical issues and approaches to increase robustness at each step of the process, and conclude that it is possible to control cost at the same time.